Carmen María Navarrete Rueda

Title: Carmen María Navarrete Rueda: Innovator in Cannabidiol Derivatives

Introduction

Carmen María Navarrete Rueda is a notable inventor based in Cordova, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of cannabidiol derivatives. Her work focuses on innovative solutions for various medical conditions.

Latest Patents

Carmen holds a patent for "Cannabidiol derivatives as inhibitors of the HIF prolyl hydroxylases activity." This patent describes cannabidiol quinol derivatives of Formula (I) and compositions that utilize these derivatives for treating conditions that benefit from the inhibition of HIF prolyl hydroxylases (PHDs) activity. The derivatives demonstrate the ability to inhibit PHD activities, stabilize HIF-1α and HIF-2α levels, activate the HIF pathway in different cell types, and induce angiogenesis in human endothelial vascular cells. These compounds are particularly useful in treating conditions such as stroke, traumatic injuries, anemia, myocardial ischemia-reperfusion injury, acute lung injury, infectious diseases, diabetic and chronic wounds, organ transplantation, acute kidney injury, and arterial diseases. Carmen has 1 patent to her name.

Career Highlights

Carmen is currently associated with Emerald Health Pharmaceuticals Inc., where she continues her research and development efforts. Her work has positioned her as a key figure in the exploration of cannabidiol's therapeutic potential.

Collaborations

Carmen has collaborated with notable colleagues, including Eduardo Muñoz Blanco and Cristina Cruz Teno, who contribute to her innovative projects and research initiatives.

Conclusion

Carmen María Navarrete Rueda is a pioneering inventor whose work in cannabidiol derivatives is paving the way for new treatments in various medical fields. Her contributions are significant and continue to impact the landscape of medicinal chemistry.